Dtsch Med Wochenschr 2017; 142(12): 912-923
DOI: 10.1055/s-0042-124260
CME-Fortbildung
© Georg Thieme Verlag KG Stuttgart · New York

Update: Kardiovaskuläre Schlafmedizin

Update: Cardiovascular Sleep Medicine
Benedikt Linz
,
Michael Böhm
,
Dominik Linz
Further Information

Publication History

Publication Date:
21 June 2017 (online)

Abstract

The prevalence of sleep-disordered breathing (SDB) is high in patients with cardiovascular diseases. Typical symptoms like daytime sleepiness can be absent and those patients may report unspecific, therapy-resistant symptoms related to their underlying disease. Particularly sleep-related symptoms like nocturia, nocturnal dyspnea and pectangina can be present. Based on the results of recently published studies, the treatment of central sleep apnea in patients with symptomatic, systolic heart failure by adaptive servo-ventilation is no longer recommended. Although the treatment of obstructive sleep apnea did not prevent cardiovascular events, it improved snoring, daytime sleepiness and health-related quality of life. Furthermore, studies imply that treatment of SDB should be considered as an adjunct treatment modality in patients with hypertension and atrial fibrillation. Due to the high prevalence, screening for SDB can help to identify patients at high cardiovascular risk.

Atemstörungen im Schlaf kommen bei Herzpatienten häufig vor – z. T. ohne die klassischen Symptome. Häufig weisen sie jedoch internistische Symptome auf, die bislang therapieresistent waren. Die Polygrafie hilft hier, Risikopatienten zu identifizieren. Neben Verhaltensregeln zählen Beatmungsmaßnahmen zu den Therapieoptionen, so z. B. CPAP bei OSA und Herzinsuffizienz. Bei ZSA und Herzinsuffizienz ist die adaptive Servoventilation nicht empfohlen.

 
  • Literatur

  • 1 Linz D, Woehrle H, Bitter T. et al. The importance of sleep-disordered breathing in cardiovascular disease. Clin Res Cardiol 2015; 104: 705-718
  • 2 Linz D, Arzt M. Schlafstörungen und Herzerkrankungen. Dtsch Med Wochenschr 2015; 140: 1272-1277
  • 3 Schäfer H, Hasper E, Ewig S. et al. Schlafbezogene Atmungsstörungen: Etabliertes und Neues in Diagnostik und Therapie. Deutsches Ärzteblatt 1996; 38: A-2396-A-2402
  • 4 Kasai T, Bradley TD. Obstructive sleep apnea and heart failure: pathophysiologic and therapeutic implications. J Am Coll Cardiol 2011; 11: 119-127
  • 5 Linz D, Linz B, Hohl M. et al. Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications. Sleep Med Rev 2016; 26: 87-94
  • 6 Linz D, Hohl M, Ukena C. et al. Obstructive respiratory events and premature atrial contractions after cardioversion. Eur Respir J 2015; 45: 1332-1340
  • 7 Linz D, Mahfoud F, Linz B. et al. Effect of obstructive respiratory events on blood pressure and renal perfusion in a pig model for sleep apnea. Am J Hypertens 2014; 27: 1293-1300
  • 8 Javaheri S, Dempsey JA. Central sleep apnea. Compr Physiol 2013; 3: 141-163
  • 9 White LH, Bradley TD. Role of nocturnal rostral fluid shift in the pathogenesis of obstructive and central sleep apnoea. J Physiol 2013; 591: 1179-1193
  • 10 Hall MJ, Xie A, Rutherford R. et al. Cycle length of periodic breathing in patients with and without heart failure. Am J Respir Crit Care Med 1996; 154: 376-381
  • 11 Oldenburg O, Arzt M, Bitter T. et al. Positionspapier „Schlafmedizin in der Kardiologie“ Update 2014. Der Kardiologe 2015; 9: 140-158
  • 12 Becker HF, Ficker J, Fietze I. et al. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie 2009; 13: 4-160
  • 13 Arzt M, Young T, Finn L. et al. Sleepiness and sleep in patients with both systolic heart failure and obstructive sleep apnea. Arch Intern Med 2006; 166: 1716-1722
  • 14 Mancia G, Fagard R, Narkiewicz K. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34: 2159-2219
  • 15 Fein AS, Shvilkin A, Shah D. et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol 2013; 62: 300-305
  • 16 Kirchhof P, Benussi S, Kotecha D. et al. Authors/Task Force Members.; Document Reviewers. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC), developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO). Eur Heart J 2016; DOI: 10.1093/eurheartj/ehw210.
  • 17 Kuniyoshi FH, Garcia-Touchard A, Gami AS. et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol 2008; 52: 343-346
  • 18 Buchner S, Satzl A, Debl K. et al. Impact of sleep-disordered breathing on myocardial salvage and infarct size in patients with acute myocardial infarction. Eur Heart J 2014; 35: 192-199
  • 19 McEvoy RD, Antic NA, Heeley E. et al. SAVE Investigators and Coordinators. CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea. N Engl J Med 2016; 375: 919-931
  • 20 Arzt M, Woehrle H, Oldenburg O. et al. SchlaHF Investigators. Prevalence and Predictors of Sleep-Disordered Breathing in Patients With Stable Chronic Heart Failure: The SchlaHF Registry. JACC Heart Fail 2016; 4: 116-125
  • 21 Oldenburg O, Faber L, Vogt J. et al. Influence of cardiac resynchronisation therapy on different types of sleep disordered breathing. Eur J Heart Fail 2007; 9: 820-826
  • 22 Bradley TD, Logan AG, Kimoff RJ. et al. CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033
  • 23 Arzt M, Floras JS, Logan AG. et al. CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 2007; 115: 3173-3180
  • 24 Cowie MR, Woehrle H, Wegscheider K. et al. Adaptive servo-ventilation for central sleep apnea in systolic heart failure. N Engl J Med 2015; 373: 1095-1105
  • 25 Ponikowski P, Voors AA, Anker SD. et al. Authors/Task Force Members2016. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37: 2129-2200
  • 26 Linz D, Fox H, Bitter T. et al. Impact of SERVE-HF on management of sleep disordered breathing in heart failure: a call for further studies. Clin Res Cardiol 2016; 105: 563-570
  • 27 Herrscher TE, Akre H, Øverland B. et al. High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function. J Card Fail 2011; 17: 420-425
  • 28 Ewen S, Nikolovska A, Zivanovic I. et al. Chronische Herzinsuffizienz – neue Erkenntnisse. Dtsch Med Wochenschr 2016; 141: 1560-1564